Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Repro Med Sys Inc (REPR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 55,184
  • Shares Outstanding, K 38,590
  • Annual Sales, $ 12,290 K
  • Annual Income, $ -530 K
  • 36-Month Beta -0.97
  • Price/Sales 4.46
  • Price/Cash Flow 237.50
  • Price/Book 6.71
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.01
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.3800 +3.62%
on 09/26/18
1.8000 -20.56%
on 10/04/18
+0.0200 (+1.42%)
since 09/18/18
3-Month
1.1800 +21.19%
on 08/29/18
1.8000 -20.56%
on 10/04/18
+0.2400 (+20.17%)
since 07/18/18
52-Week
0.4925 +190.36%
on 10/25/17
1.8000 -20.56%
on 10/04/18
+0.8700 (+155.36%)
since 10/18/17

Most Recent Stories

More News
RMS Medical Products to Report Third Quarter 2018 Results October 23, 2018

CHESTER, NY / ACCESSWIRE / October 16, 2018 / Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) today announced that it will release its financial results for the third quarter ended September...

REPR : 1.4300 (-5.30%)
UPDATE: OTC Markets Group Announces Agenda for OTCQX Virtual Investor Conference on October 4

NEW YORK, NY / ACCESSWIRE / September 26, 2018 / (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the agenda for its upcoming OTCQX® Virtual Investor...

SMDM : 0.2854 (+0.49%)
FRHC : 8.5500 (-2.84%)
LXRP : 1.8000 (+7.78%)
OTCM : 32.5000 (-1.43%)
TOMZ : 0.0850 (-2.86%)
REPR : 1.4300 (-5.30%)
MACE : 0.3295 (unch)
SOTK : 2.4000 (-3.61%)
GRWG : 4.0800 (-4.23%)
ZDPY : 0.5650 (-5.82%)
STXS : 1.3300 (-2.92%)
AMAZ : 0.2599 (-3.71%)
MNTR : 0.7600 (-4.52%)
GTBIF : 18.1385 (+3.67%)
DYAI : 1.9400 (+1.68%)
RMS Medical Products Announces Appointment of President and Chief Commercial Officer Donald Pettigrew

CHESTER, N.Y. , Sept. 4, 2018 /PRNewswire/ -- Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) today announced that Donald B. Pettigrew has been appointed to the position of President...

REPR : 1.4300 (-5.30%)
RMS Medical Products Announces Appointment of President and Chief Commercial Officer Donald Pettigrew

Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) today announced that Donald B. Pettigrew has been appointed to the position of President and Chief Commercial Officer.

REPR : 1.4300 (-5.30%)
RMS Medical Products to Present at the 7th Annual Liolis Gateway Conference

Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) today announced that Chairman and Interim President and Chief Executive Officer Dan Goldberger will be presenting at the 7th annual Liolis...

REPR : 1.4300 (-5.30%)
RMS Medical Products Announces Record Quarterly Sales and Net Income

Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) today announced financial results for the second quarter ended June 30, 2018.

REPR : 1.4300 (-5.30%)
Liolios 7th Annual Gateway Conference to Showcase 100 Leading Companies at the Four Seasons San Francisco September 5-6, 2018

Corporate Leaders from a Range of Industries to Present to 400+ Institutional Investors and Analysts

BRT : 11.48 (+0.35%)
BBSI : 62.24 (-3.97%)
DSKE : 7.33 (-4.31%)
TGO.TO : 10.40 (+1.27%)
AHT : 5.52 (-1.43%)
VERI : 8.12 (-3.91%)
CDXC : 3.69 (-1.60%)
DUOT : 0.5000 (+2.04%)
IMI : 1.03 (unch)
INUV : 0.51 (-7.27%)
JSDA : 0.3300 (-5.17%)
PRTS : 1.50 (+1.35%)
BMRA : 2.89 (-2.69%)
ESCA : 12.17 (+1.33%)
AEYE : 8.11 (-1.10%)
STKS : 3.40 (unch)
HCI : 43.52 (-0.30%)
AUTO : 2.25 (-9.27%)
PCOM : 14.49 (+2.11%)
INVE : 6.11 (+1.92%)
IMXI : 12.40 (-1.43%)
MVIS : 1.21 (-4.72%)
GMRE : 9.14 (-0.54%)
VTSI : 4.65 (+0.22%)
NTWK : 7.64 (+0.26%)
NBEV : 6.56 (+2.82%)
CLAR : 10.28 (-0.19%)
RSSS : 2.2500 (-1.32%)
TPB : 40.97 (-1.92%)
BLDP : 3.63 (-1.63%)
SBKK : 13.2700 (+1.30%)
TTGT : 19.52 (-1.86%)
ZIXI : 4.83 (-1.83%)
DZSI : 13.24 (-2.65%)
HEAR : 21.75 (-3.33%)
OOMA : 14.77 (-0.54%)
REPR : 1.4300 (-5.30%)
GAIA : 16.28 (-2.10%)
SHSP : 12.03 (-0.66%)
SRT : 6.06 (-3.66%)
GSB : 4.05 (+0.25%)
DMRC : 27.84 (-0.61%)
EVLV : 1.16 (+1.75%)
AJX.TO : 0.84 (-2.33%)
OXBR : 1.09 (-12.80%)
COWN : 16.16 (-3.92%)
SNMX : 1.49 (-0.67%)
EVOA : 0.1500 (unch)
IDSY : 6.20 (unch)
PFNX : 4.51 (+0.89%)
SELF : 3.98 (-1.00%)
MJCO : 7.43 (-3.38%)
UAVS : 0.82 (-1.20%)
CODI : 17.06 (-0.35%)
LXXGF : 0.5320 (-1.46%)
SSTI : 41.22 (-3.08%)
JAKK : 2.35 (+1.73%)
CTG : 4.92 (-7.87%)
CLFD : 12.56 (-1.26%)
AMRK : 13.53 (-2.59%)
HCAC : 10.22 (+0.49%)
PFSW : 7.07 (-0.14%)
RMS Medical Pre-Announces Strong Quarterly Sales Growth and Change in Leadership

Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) today announced top line results for the second quarter ended June 30, 2018 and organizational changes.

REPR : 1.4300 (-5.30%)
RMS Medical Products Victory as U.S. Federal Circuit Court of Appeals Invalidates EMED Technologies Corp.'s Patent, Nullifying Infringement Claim

CHESTER, NY / ACCESSWIRE / April 9, 2018 / Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR; the "Company") is pleased to announce that the United States Court of Appeals for the Federal Circuit...

REPR : 1.4300 (-5.30%)
Daniel Goldberger Nominated for Election to RMS Board of Directors

CHESTER, NY / ACCESSWIRE / March 14, 2018 / The Board of Directors of Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) today announced that seasoned senior executive and business leader Daniel...

REPR : 1.4300 (-5.30%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More Share

Trade REPR with:

Key Turning Points

2nd Resistance Point 1.5233
1st Resistance Point 1.4767
Last Price 1.4300
1st Support Level 1.4067
2nd Support Level 1.3833

See More

52-Week High 1.8000
Last Price 1.4300
Fibonacci 61.8% 1.3005
Fibonacci 50% 1.1463
Fibonacci 38.2% 0.9920
52-Week Low 0.4925

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar